Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

240. New Antimicrobial Drug Development: Saturday, 12:15 - 1:30 p.m.

Poster Session: New Antimicrobial Drug Development

(2519) A Multi-national Phase 3, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Subjects with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

Saturday, October 14, 2023
12:15 PM – 1:30 PM US ET
Location: Virtual

    Presenting Author(s)

  • Junjie Li, MD

    Attending Physician
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Institute of Respiratory Diseases, Shanghai Jiaotong University School of Medicine, Shanghai, China;
    N/A, Shanghai, China

    • Co-Author(s)

  • FW

    Feng Wei, MD

    The First People’s Hospital of Nanning, Nanning, China
    Nanning, Guangxi, China

  • PX

    Peng Xiang, MD

    Changsha Central Hospital, China
    Changsha, Hunan, China

  • ZT

    Zhengang Tang, MD

    Shiyan Renmin Hospital, Shiyan, China
    Shiyan, Hubei, China

  • LD

    Lianshu Ding, MD

    The Affiliated Huai'an First Hospital of Nanjing Medical University, Huai'an, China
    Huaian, Jiangsu, China

  • ML

    Maria C. Losada, BA

    Clinical Scientist, Clinical Research
    Merck & Co., Inc.
    Rahway, New Jersey, United States

  • ZI

    Zlatka Iamboliyska, MD

    Merck & Co., Inc., Rahway, New Jersey, USA
    South San Francisco CA, California, United States

  • MZ

    Mingfen Zhu, MD

    MSD, China
    Xuhui district, Shanghai, China

  • XG

    Xiaodan Guo, MD

    MSD, China
    Xuhui District, Shanghai, China

  • XD

    Xiaoling Du, n/a

    MSD, China
    Shanghai, Shanghai, China

  • CC

    Chang Chen, MD

    MSD, China
    Xuhui District, Shanghai, China

  • LC

    Luke Francis Chen, MD

    Merck & Co., Inc., Rahway, New Jersey, USA
    Rahway, New Jersey, United States

  • MZ

    Min Zhou, MD

    Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Institute of Respiratory Diseases, Shanghai Jiaotong University School of Medicine, Shanghai, China
    N/A, Shanghai, China

  • JQ

    Jieming Qu, MD

    Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Institute of Respiratory Diseases, Shanghai Jiaotong University School of Medicine, Shanghai, China
    N/A, Shanghai, China